Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

G. Procopio; M. Prisciandaro; R. Iacovelli; E. Cortesi; G. Fornarini; G. Facchini; G. Cartenì; R. Sabbatini; G. Del Bene; L. Galli; C. Caserta; A.G. Multari; M. Bregni; F. Massari; S. Buti; U. De Giorgi; F. Zustovich; M. Milella; F. Calabrò; M.L. Mancini; G. Tortora; C. Vernieri; D. Santini; M. Sorarù; R. Ricotta; Cristina Masini; M. Tucci; S.L. Fedeli; C. Ortega; A. Mecozzi; R. Ratta; C.N. Sternberg; E. Verzoni

doi:10.1016/j.clgc.2018.03.014

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

G. Procopio, M. Prisciandaro, R. Iacovelli, E. Cortesi, G. Fornarini, G. Facchini, G. Cartenì, R. Sabbatini, G. Del Bene, L. Galli, C. Caserta, A.G. Multari, M. Bregni, F. Massari, S. Buti, U. De Giorgi, F. Zustovich, M. Milella, F. Calabrò, M.L. ManciniG. Tortora, C. Vernieri, D. Santini, M. Sorarù, R. Ricotta, Cristina Masini, M. Tucci, S.L. Fedeli, C. Ortega, A. Mecozzi, R. Ratta, C.N. Sternberg, E. Verzoni

Research output: Contribution to journal › Article

Original language	Italian
Pages (from-to)	e945-e951
Journal	Clinical Genitourinary Cancer
Volume	16
Issue number	4
DOIs	https://doi.org/10.1016/j.clgc.2018.03.014
Publication status	Published - 2018

Access to Document

10.1016/j.clgc.2018.03.014

https://www.scopus.com/inward/record.uri?eid=2-s2.0-85046658578&doi=10.1016%2fj.clgc.2018.03.014&partnerID=40&md5=a4b899a6b2d737bfd3f5628b8a59e8d9

Cite this

Procopio, G., Prisciandaro, M., Iacovelli, R., Cortesi, E., Fornarini, G., Facchini, G., Cartenì, G., Sabbatini, R., Del Bene, G., Galli, L., Caserta, C., Multari, A. G., Bregni, M., Massari, F., Buti, S., De Giorgi, U., Zustovich, F., Milella, M., Calabrò, F., ... Verzoni, E. (2018). Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program. Clinical Genitourinary Cancer, 16(4), e945-e951. https://doi.org/10.1016/j.clgc.2018.03.014

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program. / Procopio, G.; Prisciandaro, M.; Iacovelli, R.; Cortesi, E.; Fornarini, G.; Facchini, G.; Cartenì, G.; Sabbatini, R.; Del Bene, G.; Galli, L.; Caserta, C.; Multari, A.G.; Bregni, M.; Massari, F.; Buti, S.; De Giorgi, U.; Zustovich, F.; Milella, M.; Calabrò, F.; Mancini, M.L.; Tortora, G.; Vernieri, C.; Santini, D.; Sorarù, M.; Ricotta, R.; Masini, Cristina; Tucci, M.; Fedeli, S.L.; Ortega, C.; Mecozzi, A.; Ratta, R.; Sternberg, C.N.; Verzoni, E.

In: Clinical Genitourinary Cancer, Vol. 16, No. 4, 2018, p. e945-e951.

Research output: Contribution to journal › Article

Procopio, G, Prisciandaro, M, Iacovelli, R, Cortesi, E, Fornarini, G , Facchini, G, Cartenì, G, Sabbatini, R, Del Bene, G, Galli, L, Caserta, C, Multari, AG, Bregni, M, Massari, F, Buti, S, De Giorgi, U, Zustovich, F, Milella, M, Calabrò, F, Mancini, ML, Tortora, G, Vernieri, C, Santini, D, Sorarù, M, Ricotta, R, Masini, C, Tucci, M, Fedeli, SL, Ortega, C, Mecozzi, A, Ratta, R, Sternberg, CN & Verzoni, E 2018, 'Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program', Clinical Genitourinary Cancer, vol. 16, no. 4, pp. e945-e951. https://doi.org/10.1016/j.clgc.2018.03.014

Procopio, G. ; Prisciandaro, M. ; Iacovelli, R. ; Cortesi, E. ; Fornarini, G. ; Facchini, G. ; Cartenì, G. ; Sabbatini, R. ; Del Bene, G. ; Galli, L. ; Caserta, C. ; Multari, A.G. ; Bregni, M. ; Massari, F. ; Buti, S. ; De Giorgi, U. ; Zustovich, F. ; Milella, M. ; Calabrò, F. ; Mancini, M.L. ; Tortora, G. ; Vernieri, C. ; Santini, D. ; Sorarù, M. ; Ricotta, R. ; Masini, Cristina ; Tucci, M. ; Fedeli, S.L. ; Ortega, C. ; Mecozzi, A. ; Ratta, R. ; Sternberg, C.N. ; Verzoni, E. / Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program. In: Clinical Genitourinary Cancer. 2018 ; Vol. 16, No. 4. pp. e945-e951.

@article{00217ca2c4484dc3b9fc55caf0189f88,

title = "Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program",

author = "G. Procopio and M. Prisciandaro and R. Iacovelli and E. Cortesi and G. Fornarini and G. Facchini and G. Carten{\`i} and R. Sabbatini and {Del Bene}, G. and L. Galli and C. Caserta and A.G. Multari and M. Bregni and F. Massari and S. Buti and {De Giorgi}, U. and F. Zustovich and M. Milella and F. Calabr{\`o} and M.L. Mancini and G. Tortora and C. Vernieri and D. Santini and M. Sorar{\`u} and R. Ricotta and Cristina Masini and M. Tucci and S.L. Fedeli and C. Ortega and A. Mecozzi and R. Ratta and C.N. Sternberg and E. Verzoni",

note = "Cited By :2 Export Date: 1 February 2019",

year = "2018",

doi = "10.1016/j.clgc.2018.03.014",

language = "Italian",

volume = "16",

pages = "e945--e951",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier Inc.",

number = "4",

}

TY - JOUR

T1 - Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

AU - Procopio, G.

AU - Prisciandaro, M.

AU - Iacovelli, R.

AU - Cortesi, E.

AU - Fornarini, G.

AU - Facchini, G.

AU - Cartenì, G.

AU - Sabbatini, R.

AU - Del Bene, G.

AU - Galli, L.

AU - Caserta, C.

AU - Multari, A.G.

AU - Bregni, M.

AU - Massari, F.

AU - Buti, S.

AU - De Giorgi, U.

AU - Zustovich, F.

AU - Milella, M.

AU - Calabrò, F.

AU - Mancini, M.L.

AU - Tortora, G.

AU - Vernieri, C.

AU - Santini, D.

AU - Sorarù, M.

AU - Ricotta, R.

AU - Masini, Cristina

AU - Tucci, M.

AU - Fedeli, S.L.

AU - Ortega, C.

AU - Mecozzi, A.

AU - Ratta, R.

AU - Sternberg, C.N.

AU - Verzoni, E.

N1 - Cited By :2 Export Date: 1 February 2019

PY - 2018

Y1 - 2018

U2 - 10.1016/j.clgc.2018.03.014

DO - 10.1016/j.clgc.2018.03.014

M3 - Articolo

VL - 16

SP - e945-e951

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

SN - 1558-7673

IS - 4

ER -